Modification and inactivation of Cu,Zn-superoxide dismutase by the lipid peroxidation product, acrolein

BMB Reports

Volumn 46, Issue 11, 2013, Pages 555-560

  Kang, Jung Hoon ^a  

^a Chongju University   (South Korea)

Author keywords

Acrolein; Cu; Lipid peroxidation; Reactive oxygen species; Zn superoxide dismutase

Indexed keywords

ACROLEIN; AMINO ACID; CHELATING AGENT; COPPER; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; SCAVENGER; SUPEROXIDE DISMUTASE;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; PROTEIN CARBONYLATION;

ACROLEIN; AMINO ACIDS; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; HUMANS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE;

EID: 84890215304     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.11.138     Document Type: Article

References (43)

1. Good, P. F., Perl, D. P., Bierer, L. M. and Schmeidler, J. (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 281-292.
2. Cornett, C. R., Markesbery, W. R. and Ehmann, W.D. (1998) Imbalance of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-346.
3. Smith, M. A., Harris, P. L., Sayre, L. M. and Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 94, 9866-9868.
4. Lovell, M. A., Ehmann, W. D., Butler, S. M. and Markesbery, W. R. (1995) Elevated thiobarbituric acid-reacive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
5. Svennerholm, L. and Gottfries, C. G. (1994) Membrane lipids, selectively diminished in Alzheimer brain, suggest synapse loss as a primary event in early- onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047.
6. Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. and Markesbery, W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81-83.
7. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., Lovell, M. A., Markesbery, W. R. and Butterfield, D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
8. Gabbita, S. P., Aksenov, M. Y., Lovell, M. A. and Markesbery, W. R. (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73, 1600-1666.
9. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N. and Niki, E. (1998) Acrolein ins a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273, 16058-16066.
10. Esterbauer, H., Schaur, R. J. and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
11. Chung, F. L., Young, R. and Hecht, S. S. (1984) Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 44, 990-995.
12. Marnett, L. J. (1994) DNA adducts of a,'-unsaturated aldehydes and dicarbonyl compounds. IARC Sci. Publ. 125, 151-163.
13. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E. and Osawa, T. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 95, 4882-4887.
14. Klug, D., Rabani, J. and Fridovich, I. (1972) A direct demonstration of thye catalytic action of superoxide dismutase through the use of pulse radiolysis. J. Biol. Chem. 247, 4839-4842.
15. Uchida, K. and Kawakishi, S. (1994) Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J. Biol. Chem. 269, 2405-2410.
16. Choi, S. Y., Kwon, H. Y., Kwon, O. B. and Kang J. H. (1999) Hydrogen peroxide-mediated Cu,Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine. Biochim. Biophys. Acta. 1472, 651-657.
17. Kwon, O. J., Lee, S. M., Floyd, R. A. and Park, J. W. (1998) Thiol-dependent metal-catalyzed oxidation of copper, zinc superoxide dismutase. Biochim. Biophys. Acta. 1387, 249-256.
18. Masiello, P., Triumbari, F., Leone, R., Itri, F., Del Negro, G. and Di Benedetto, G. (1999) Extended vertical transseptal approach versus conventional left atriotomy for mitral valve surgery. J. Heart Valve Dis. 8, 440-444.
19. Ookawara, T., Kawamura, N., Kitagawa, Y. and Taniguchi, N. (1992) Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J. Biol. Chem. 2667, 18505-18510.
20. Levine, R. L., Williams, J. A., Stadtman, E. R. and Shacter, E. (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346-357.
21. Towbin, H., Staehlon, T. and Gordon, J. (1979) Electrophoretic transfer of poteins rom polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354.
22. Bray, R. C., Cokle, S. H., Fielden, E. M., Roberts, P. B., Rotilio, G. and Calabrese, I. (1974) Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem. J. 139, 43-48.
23. Calingansan, N. Y., Uchida, K. and Gibson, G. E. (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72, 751-756.
24. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B. and Smith, M. A. (2001) Oxidative damage is the earliest even in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
25. Catala, A. (2009) Lipid peroxidation of membrane phopholipids generates hydroxyl-alkenals and oxidized phopholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157, 1-11.
26. Mythili, Y., Sudharsan, P. T., Selvakumar, E. and Varalakshmi, P. (2004) Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem. Biol. Interact. 30, 13-19.
27. Luo, J. and Shi, R. (2004) Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 44, 475-486.
28. Luo, J. and Shi, R. (2004) Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 46, 443-452.
29. Arumugam, N., Sivakumar, V., Thanislass, J. and Devaraj, H. (1997) Effects of acrolein on rat liver antioxidant defense system. Indian J. Exp. Biol. 35, 1373-1374.
30. Gubler, C. J., Lahey, M. E., Ashenbrrucker, H., Cartwright, G. E., and Wintrobe, M. M. (1952) Studies on copper metabolism I. A method for the determination of copper in whole blood, red blood cells, and plasma. J. Biol. Chem. 196, 209-220.
31. Haniguchi, T., Hirata, F. and Hayaishi, O. (1977) Intracellular utilization of superoxide anion by indoleamine 2,3-dioxygenase of rabbit enterocytes. J. Biol. Chem. 252, 2774-2776.
32. Misra, H. P. (1979) Reaction of copper-zinc superoxide dismutase with diethyldithiocarbamate. J. Biol. Chem. 254, 11623-11628.
33. Halliwell, B. and Gutteridge, J. M. C. (1999) Free Radicals in Biology and Medicine, Oxford, New York, USA.
34. O'Connell, M. J. and Peters, T. J. (1987) Ferritin and haemosiderin in free radical generation, lipid peroxidation and protein damage. Chem. Phys. Lipids 45, 241-249.
35. Multhaup, G., Schlicksupp, A., Hesse, L., Behler, D., Ruppert, T., Masters, C. L. and Beyreuther, K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409.
36. Bush, A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207-214.
37. Refsgaardm, H. H., Tsai, L. and Stadman, E. R. (2000) Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc. Natl. Acad. Sci. U. S. A. 97, 611-616.
38. Maria, C. S., Revilla, E., Ayala, A., de la Cruz, C. P. and Machado, A. (1995) Changes in the histidine residues of Cu/Zn superoxide dismutase during aging. FEBS Lett. 374, 85-88.
39. Tainer, J. A., Gertzoff, E. D., Richardson, J. S. and Richardson, D. C. (1983) Structure and mechanism of copper,zinc superoxide dismutase. Nature 306, 284-287.
40. Kang J. H., Choi, B. J. and Kim, S. M. (1997) Expression and characterization of recombinant human Cu,Zn-superoxide dismutase in Escherichia coli. J. Biochem. Mol. Biol. 30, 60-65.
41. McCord, J. M. and Fridovich, I. (1969) Superoxide dismutase. J. Biol. Chem. 224, 6049-6055.
42. Kang, J. H. (2012) Salsolinol, a tetrahydroisoquinoline- derived neurotoxin, induces oxidative modification of neurofilament-L: protection by histidyl dipeptides. BMB Rep. 45, 114-119.
43. An, S. H., Lee, M. S. and Kang, J. H. (2012) Oxidative modification of ferritin induced by methylglyoxal. BMB Rep. 45, 147-152.